Global Preclinical Imaging Market by Product (Modalities, Reagents), Application (Drug Discovery, Research & Development), End-User - Forecast 2024-2030- Product Image

Sale

Global Preclinical Imaging Market by Product (Modalities, Reagents), Application (Drug Discovery, Research & Development), End-User - Forecast 2024-2030

Report
196 Pages
June 2024
Region: Global
360iResearch™
ID: 4968721

UP TO €673EUR$697USD£570GBP OFF until Dec 31^st 2024

The Preclinical Imaging Market grew from USD 2.48 billion in 2023 to USD 2.60 billion in 2024. It is expected to continue growing at a CAGR of 4.91%, reaching USD 3.48 billion by 2030.

Preclinical imaging uses various imaging techniques to visualize and study the anatomy, function, and metabolism of organs and tissues in small laboratory animals. These non-invasive techniques do not require surgical procedures to observe the body's internal workings. Key techniques include MRI, PET, SPECT, CT, optical imaging, and ultrasound, which provide critical insights for drug development, genetic research, cancer studies, neurological studies, and cardiovascular investigations. As pharmaceutical and biotechnology companies invest more in R&D, the need for precise and efficient preclinical imaging grows. The increasing need to understand and treat chronic diseases fuels the need for preclinical imaging in disease mechanism studies and drug development. Increasing investment in drug discovery and clinical trials necessitates robust preclinical testing, contributing to market growth. High cost and technical complexity associated with preclinical imaging hamper the market growth. Rising development of non-invasive techniques, enhancing image resolution, creating portable imaging systems, and applying these technologies to emerging fields, including regenerative medicine and immunotherapy, are expected to create opportunities for market growth.

Regional Insights

In the Americas, the market for preclinical imaging is propelled by substantial investments in pharmaceutical R&D, a strong presence of key market players, and robust academic and research institutions. South America is also showing promising growth, with countries including Brazil and Argentina investing more in healthcare infrastructure and research, supported by government initiatives and increasing collaborations with global pharmaceutical companies. The APAC region is witnessing rapid growth due to increasing healthcare expenditures, an expanding biotechnology sector, and a rising number of CROs catering to global pharmaceutical companies. Additionally, government initiatives to boost research infrastructure in countries including China and India further fuel the market. In the EMEA region, the market benefits from strong government support for research activities, established healthcare infrastructure, and collaborative efforts between academic institutions and industry players. Europe's focus on advanced medical research and the adoption of cutting-edge imaging technologies also contribute significantly to market growth in this region. In the Middle East, countries including Saudi Arabia and the UAE invest heavily in healthcare and research infrastructure, aiming to become regional medical research and innovation hubs. Africa is growing in the preclinical imaging market with increasing support for healthcare projects and partnerships with international organizations.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Preclinical Imaging Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

Increasing research & development activities by pharmaceutical companies
Growing government investment and funding for expanding biomedical research
Rising number of clinical research organizations (CROs)

Market Restraints

High cost of imaging equipment and maintenance of preclinical imaging

Market Opportunities

Increasing incorporation of advanced technologies in preclinical imaging to improve image analysis
Rising focus on the development of personalized medicines

Market Challenges

Strict regulations and ethical concerns associated with animal research

Market Segmentation Analysis

Product: Growing usage of modalities in preclinical studies for specific research needs
End-User: Increasing adoption of preclinical imaging by pharmaceutical & biopharmaceutical companies to develop new drugs

Industry Insights

Market Disruption Analysis
Porter’s Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Preclinical Imaging Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Preclinical Imaging Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Revvity, Inc.’s Innovative Preclinical Imaging Solutions Unveiled at WMIC 2023

Revvity, Inc. unveiled an enhanced imaging portfolio aimed at revolutionizing preclinical research. Key innovations include the IVIS Spectrum 2 and IVIS SpectrumCT 2 systems, which set new benchmarks for in vivo optical imaging versatility and sensitivity. Additionally, the Quantum GX3 microCT offers heightened resolution and speed for comprehensive in vivo and ex vivo imaging, aiding researchers in disease biology and therapeutic evaluation.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Preclinical Imaging Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Preclinical Imaging Market, highlighting leading vendors and their innovative profiles. These include Advanced Molecular Vision, Inc., Angstrom Advanced Inc., Aspect Imaging Ltd., Berthold Technologies, Bruker Corporation, Euro-BioImaging ERIC, FUJIFILM Holdings America Corporation, IVIM Technology Corp., KUBTEC Technology, LI-COR, Inc., Mediso Ltd., Milabs BV, Miltenyi Biotec GmbH, MR Solutions Group, Peira bvba, PerkinElmer Inc., Revvity, Inc., Scitech Pty Ltd., and United Imaging Healthcare Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Preclinical Imaging Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product- Modalities

Magnetic Particle Imaging
Magnetic Resonance Imaging
Micro-Computed Tomography
Optical Imaging
Positron Emission Tomography
Single-Photon Emission Computed Tomography

Reagents

Bioluminescent Imaging Reagents
Fluorescent Imaging Reagents
MRI Contrasting Reagents
PET Radioactive Tracers
Ultrasound Contrasting Reagents
X-ray CT Contrasting Reagents

Application

Drug Discovery
Research & Development

End-User

Academic & Government Research Institutes
Contract Research Organizations (CROs)
Pharmaceutical & Biotechnology Companies

Region

Americas

Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas

Asia-Pacific

Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam

Europe, Middle East & Africa

Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing research & development activities by pharmaceutical companies
5.1.1.2. Growing government investment and funding for expanding biomedical research
5.1.1.3. Rising number of clinical research organizations (CROs)
5.1.2. Restraints
5.1.2.1. High cost of imaging equipment and maintenance of preclinical imaging
5.1.3. Opportunities
5.1.3.1. Increasing incorporation of advanced technologies in preclinical imaging to improve image analysis
5.1.3.2. Rising focus on the development of personalized medicines
5.1.4. Challenges
5.1.4.1. Strict regulations and ethical concerns associated with animal research
5.2. Market Segmentation Analysis
5.2.1. Product: Growing usage of modalities in preclinical studies for specific research needs
5.2.2. End-User: Increasing adoption of preclinical imaging by pharmaceutical & biopharmaceutical companies to develop new drugs
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. Preclinical Imaging Market, by Product

6.1. Introduction
6.2. Modalities
6.3. Reagents

7. Preclinical Imaging Market, by Application

7.1. Introduction
7.2. Drug Discovery
7.3. Research & Development

8. Preclinical Imaging Market, by End-User

8.1. Introduction
8.2. Academic & Government Research Institutes
8.3. Contract Research Organizations (CROs)
8.4. Pharmaceutical & Biotechnology Companies

9. Americas Preclinical Imaging Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Preclinical Imaging Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Preclinical Imaging Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Revvity, Inc.’s Innovative Preclinical Imaging Solutions Unveiled at WMIC 2023
12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

13.1. Key Company Profiles
13.2. Key Product Portfolio

List of Figures

FIGURE 1. PRECLINICAL IMAGING MARKET RESEARCH PROCESS
FIGURE 2. PRECLINICAL IMAGING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL PRECLINICAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. PRECLINICAL IMAGING MARKET DYNAMICS
FIGURE 7. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. PRECLINICAL IMAGING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. PRECLINICAL IMAGING MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. PRECLINICAL IMAGING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL PRECLINICAL IMAGING MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL PRECLINICAL IMAGING MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MAGNETIC PARTICLE IMAGING, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MAGNETIC PARTICLE IMAGING, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MICRO-COMPUTED TOMOGRAPHY, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MICRO-COMPUTED TOMOGRAPHY, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY OPTICAL IMAGING, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY OPTICAL IMAGING, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENT IMAGING REAGENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENT IMAGING REAGENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENT IMAGING REAGENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENT IMAGING REAGENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MRI CONTRASTING REAGENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MRI CONTRASTING REAGENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY PET RADIOACTIVE TRACERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY PET RADIOACTIVE TRACERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY ULTRASOUND CONTRASTING REAGENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY ULTRASOUND CONTRASTING REAGENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY X-RAY CT CONTRASTING REAGENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY X-RAY CT CONTRASTING REAGENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 55. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 56. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 57. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 58. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 59. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 60. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 61. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 62. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 63. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 64. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 65. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 66. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 67. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 68. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 69. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 70. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 71. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 72. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 73. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 74. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 75. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 76. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 77. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 78. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 79. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 80. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 81. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 82. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 83. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 84. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 85. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 86. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 87. CANADA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 88. CANADA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 89. CANADA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 90. CANADA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 91. CANADA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 92. CANADA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 93. CANADA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 94. CANADA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 95. CANADA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 96. CANADA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 97. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 98. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 99. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 100. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 101. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 102. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 103. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 104. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 105. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 106. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 107. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 108. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 109. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 110. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 111. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 112. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 113. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 114. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 115. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 116. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 117. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 118. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 119. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 120. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 121. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 122. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 123. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 124. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 125. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 126. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 127. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 128. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 129. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 130. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 131. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 132. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 133. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 134. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 135. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 136. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 137. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 138. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 139. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 140. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 141. CHINA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 142. CHINA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 143. CHINA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 144. CHINA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 145. CHINA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 146. CHINA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 147. CHINA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 148. CHINA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 149. CHINA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 150. CHINA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 151. INDIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 152. INDIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 153. INDIA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 154. INDIA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 155. INDIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 156. INDIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 157. INDIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 158. INDIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 159. INDIA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 160. INDIA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 161. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 162. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 163. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 164. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 165. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 166. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 167. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 168. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 169. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 170. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 171. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 172. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 173. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 174. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 175. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 176. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 177. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 178. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 179. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 180. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 181. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 182. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 183. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 184. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 185. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 186. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 187. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 188. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 189. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 190. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 191. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 192. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 193. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 194. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 195. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 196. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 197. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 198. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 199. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 200. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 201. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 202. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 203. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 204. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 205. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 206. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 207. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 208. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 209. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 210. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 211. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 212. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 213. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 214. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 215. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 216. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 217. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 218. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 219. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 220. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 221. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 222. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 223. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 224. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 225. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 226. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 227. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 228. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 229. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 230. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 231. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 232. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 233. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 234. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 235. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 236. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 237. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 238. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 239. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 240. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 241. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 242. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 243. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 244. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 245. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 246. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 247. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 248. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 249. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 250. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 263. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 264. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 265. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 266. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 267. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 268. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 269. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 270. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 271. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 272. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 273. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 274. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 275. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 276. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 277. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 278. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 279. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 280. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 281. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 282. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 283. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 284. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 285. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 286. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 287. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 288. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 289. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 290. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 291. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 292. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 293. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 294. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 295. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 296. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 297. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 298. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 299. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 300. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 301. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 302. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 303. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 304. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 305. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 306. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 307. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 308. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 309. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 310. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 311. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 312. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 313. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 314. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 315. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 316. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 317. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 318. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 319. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 320. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 321. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 322. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 323. ITALY PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 324. ITALY PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 325. ITALY PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 326. ITALY PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 327. ITALY PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 328. ITALY PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 329. ITALY PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 330. ITALY PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 331. ITALY PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 332. ITALY PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 333. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 334. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 335. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 336. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 337. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 338. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 339. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 340. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 341. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 342. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 343. NIGERIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 344. NIGERIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 345. NIGERIA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 346. NIGERIA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 347. NIGERIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 348. NIGERIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 349. NIGERIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 350. NIGERIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 351. NIGERIA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2

Companies Mentioned

Advanced Molecular Vision, Inc.
Angstrom Advanced Inc.
Aspect Imaging Ltd.
Berthold Technologies
Bruker Corporation
Euro-BioImaging ERIC
FUJIFILM Holdings America Corporation
IVIM Technology Corp.
KUBTEC Technology
LI-COR, Inc.
Mediso Ltd.
Milabs BV
Miltenyi Biotec GmbH
MR Solutions Group
Peira bvba
PerkinElmer Inc.
Revvity, Inc.
Scitech Pty Ltd.
United Imaging Healthcare Co., Ltd.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	196
Published	June 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 2.6 Billion
Forecasted Market Value ( USD ) by 2030	$ 3.48 Billion
Compound Annual Growth Rate	4.9%
Regions Covered	Global
No. of Companies Mentioned	19

PURCHASE OPTIONS

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3423EUR$3,545USD£2,901GBP €3803EUR$3,939USD£3,223GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€4300EUR$4,454USD£3,645GBP €4778EUR$4,949USD£4,050GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€6056EUR$6,272USD£5,132GBP €6729EUR$6,969USD£5,702GBP